---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-262140"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2022-10-13T23:59:59+00:00"
generated_at: "2026-06-23T03:43:46.513107+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Acadia appoints Adora Ndu to board, increases size to nine directors

## Summary
- Board increased from 8 to 9 members; Adora Ndu, Pharm.D., J.D. appointed effective Oct 12, 2022.
- Dr. Ndu serves as Class I director with term expiring at 2023 Annual Meeting.
- Receives standard director compensation: stock option and RSU award each with $150,000 fair value.
- Will not initially serve on any board committees.

## SEC filing metadata
- accession: 0001193125-22-262140
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2022-10-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312522262140/0001193125-22-262140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312522262140/d412468d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-262140
- JSON: https://secwatch.observer/filing/0001193125-22-262140.json
- Plain text: https://secwatch.observer/filing/0001193125-22-262140.txt

## Key facts
- Executive change
  Adora Ndu was appointed as Director at ACADIA PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Director
  source text: appointed Adora Ndu, Pharm.D., J.D. as a director to fill the newly created vacancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1070494/000119312522262140/0001193125-22-262140-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.